CuraRN

NSG210 Hinkle Ch. 21: Assessment of Cardiovascular Function

Source: Hinkle & Cheever, Brunner & Suddarth’s Medical-Surgical Nursing 15e, Chapter 21, pp. 650-690 (textbooks/HINKLE_MS_CH21.pdf, also in textbooks/exam01/). Week 02 reading; on Exam 1 (CV assessment was 2 of 34 med-surg questions, but the content underlies heart failure and arrhythmias). Numbering note: the raw lecture plan lists “Ch. 22 - cardiovascular assessment,” but in the 15th edition assessment is Ch. 21; the exam01 folder holds Ch. 21. See also nsg210-week-02-summary.

Learning Outcomes

  1. Describe cardiovascular structure, function, and cardiac risk factors.
  2. Perform a comprehensive cardiovascular assessment.
  3. Discriminate normal and abnormal findings by inspection, palpation, percussion, and auscultation.
  4. Recognize major manifestations of cardiovascular dysfunction from history and physical findings.
  5. Identify diagnostic tests and hemodynamic monitoring (CVP, pulmonary artery, arterial pressure) and nursing implications.

Key terms:

I. Anatomic and Physiologic Overview

A. Heart structure

B. Valves

C. Coronary arteries

D. Conduction system

E. Action potential

F. Hemodynamics

G. Gerontologic and gender considerations (Table 21-1)

II. Health History

Common symptoms of CVD:

Assessing chest pain (Table 21-2):

Other history:

III. Physical Assessment

Evaluate: heart as a pump, filling volumes and pressures, cardiac output, compensatory mechanisms.

A. General appearance

B. Skin and extremities (Table 21-3)

C. Blood pressure

Orthostatic BP (Chart 21-3):

D. Arterial pulses

E. Jugular venous pulsations

F. Heart inspection and palpation (Fig. 21-5)

G. Auscultation

H. Other systems

IV. Diagnostic Evaluation

A. Laboratory tests (Table 21-4)

Lipids (12-hour fast):

Other markers:

B. Imaging and ECG

Continuous ECG monitoring:

Ambulatory monitoring:

C. Stress testing

Exercise stress test:

Pharmacologic stress test:

D. Radionuclide imaging

E. CT, MRA, echocardiography

F. Cardiac catheterization

Before:

After:

G. Electrophysiology study

H. Hemodynamic monitoring

High-Yield Numbers

Priority Nursing Actions and Red Flags

Medications and Agents in This Chapter

Agent Use Nursing considerations
Aspirin plus clopidogrel, prasugrel, or ticagrelor Dual antiplatelet therapy after ACS or stent Aspirin lifelong; P2Y12 inhibitor 1-12 months; bleeding; adherence critical
Heparin Anticoagulation during procedures Monitor aPTT (1.5-2.5 times baseline)
Warfarin Oral anticoagulant Monitor PT/INR (usually 2-3.5)
Glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban) Platelet inhibition Thrombocytopenia, bleeding
Statins, ezetimibe, bile acid sequestrants, PCSK9 inhibitors Lower cholesterol Lipid monitoring
Dipyridamole, adenosine, regadenoson Pharmacologic stress vasodilators No caffeine 24 hours; flushing, chest pain, heart block; reverse with aminophylline
Dobutamine Pharmacologic stress (with echo) Raises HR, BP, contractility
Aminophylline Reverses vasodilator stress agents Hold theophylline products before vasodilator stress tests
Contrast agents Angiography, CT CIN risk; IV hydration; premedicate with antihistamine and steroid if prior reaction
Atropine Vasovagal bradycardia after cath IV
Beta-blockers (propranolol, metoprolol) Various Decrease contractility; nonselective may cause wheezing; may be held before stress test